Applied DNA Sciences (NASDAQ:APDN) announced its quarterly earnings results on Tuesday. The technology company reported ($0.04) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.06) by $0.02, Morningstar.com reports. Applied DNA Sciences had a negative return on equity of 1,286.88% and a negative net margin of 317.32%. The business had revenue of $2.05 million for the quarter.
Shares of Applied DNA Sciences stock traded down $0.05 during trading hours on Wednesday, hitting $0.27. The company’s stock had a trading volume of 200 shares, compared to its average volume of 515,360. Applied DNA Sciences has a twelve month low of $0.25 and a twelve month high of $1.84. The company’s fifty day simple moving average is $0.39. The company has a quick ratio of 1.10, a current ratio of 1.24 and a debt-to-equity ratio of 2.82.
Separately, Maxim Group reaffirmed a “hold” rating on shares of Applied DNA Sciences in a research note on Wednesday, June 12th.
Applied DNA Sciences Company Profile
Applied DNA Sciences, Inc develops and markets plat based or other DNA technology solution in the United States, Europe, and Asia. The company's supply chain security and product authentication solutions include SigNature molecular tags that are ingredients used to fortify brand protection efforts and strengthen supply chain security, as well as mark, track, and convict criminals; SigNature T molecular tags, which are tagging and authentication systems for use in brand protection efforts and raw material source compliance programs; and fiberTyping, a test of native cotton fiber DNA.
Featured Article: What is meant by holder of record?
Receive News & Ratings for Applied DNA Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied DNA Sciences and related companies with MarketBeat.com's FREE daily email newsletter.